Literature DB >> 2685736

Isogenic group B streptococci devoid of capsular polysaccharide or beta-hemolysin: pulmonary hemodynamic and gas exchange effects during bacteremia in piglets.

R L Gibson1, G J Redding, W E Truog, W R Henderson, C E Rubens.   

Abstract

Group B beta-hemolytic streptococcus (GBS) causes thromboxane (Tx)-associated pulmonary hypertension and hypoxemia in neonatal animals and human infants. The components of GBS that induce these features of sepsis are incompletely characterized. The capsular polysaccharide has been implicated based on the effects of GBS extracts. We used isogenic mutants of a parent GBS strain (COH 31 r/s) devoid of capsular polysaccharide or beta-hemolysin to determine if these components caused the acute features of GBS bacteremia. In neonatal piglets, we observed a similar increase in pulmonary vascular resistance (PVR, mm Hg/L/min) during a 1 h infusion at 5 x 10(8) colony-forming unit/kg/h of COH 31 r/s (n = 5, 11.6 +/- 1.4 to 67.1 +/- 17.9), an isogenic GBS mutant devoid of type III CP (n = 5, 12.5 +/- 1.4 to 56.9 +/- 5.0), and an isogenic GBS mutant devoid of beta-hemolysin (n = 4, 11.0 +/- 1.9 to 51.9 +/- 7.9). All three GBS strains caused increases in blood TxB2 levels, mild arterial hypoxemia, mild reduction in mixed venous PO2, and a 30-40% reduction in cardiac output after a 1 h infusion. The Tx-synthase inhibitor, dazmegrel, completely reversed pulmonary hypertension, and partially reversed arterial hypoxemia and TxB2 levels to baseline values for all GBS strains. In six additional piglets, infusion of polystyrene beads of similar size to GBS at a dose of 5 x 10(8) beads/kg/h caused no changes in gas exchange or blood TxB2 levels, but a mild increase in PVR (13.3 +/- 2.0 to 17.7 +/- 3.5).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2685736     DOI: 10.1203/00006450-198909000-00017

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

Review 1.  Group B Streptococcus, phospholipids and pulmonary hypertension.

Authors:  J Curtis; G Kim; N B Wehr; R L Levine
Journal:  J Perinatol       Date:  2011-04       Impact factor: 2.521

2.  Group B streptococcal phospholipid causes pulmonary hypertension.

Authors:  Jerri Curtis; Geumsoo Kim; Nancy B Wehr; Rodney L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

3.  Group B Streptococcus and E. coli LPS-induced NO-dependent hyporesponsiveness to noradrenaline in isolated intrapulmonary arteries of neonatal piglets.

Authors:  E Villamor; F Pérez-Vizcaíno; T Ruiz; J C Leza; M Moro; J Tamargo
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

4.  Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci.

Authors:  G Mancuso; F Tomasello; C von Hunolstein; G Orefici; G Teti
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

5.  Impairment of brain mitochondrial functions by β-hemolytic Group B Streptococcus. Effect of cardiolipin and phosphatidylcholine.

Authors:  Lara Macchioni; Katia Fettucciari; Magdalena Davidescu; Rita Vitale; Pamela Ponsini; Emanuela Rosati; Angela Corcelli; Pierfrancesco Marconi; Lanfranco Corazzi
Journal:  J Bioenerg Biomembr       Date:  2013-08-25       Impact factor: 2.945

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.